Next 10 |
home / stock / bimuf / bimuf news
VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise. First,...
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences,...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / December 2, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) (" Pascal " or the "Company") and SōRSE Technology Corporation (" SōRSE ") have validated and optimized a formula for oral cannabinoid delivery....
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the appointment of Mark van der Horst to the position of Vice President of Corporate Communications. Mr. van der Horst has been CEO...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 23, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has confirmed an earlier report that certain cannabinoids block replication of SARS-CoV-2, the coronavirus that causes ...
Pascal Biosciences ( OTC:BIMUF ) and SōRSE Technology have entered into a Collaborative Research Agreement to advance Pascal’s PAS-393 into clinical testing. More news on: Pascal Biosciences Inc., Healthcare stocks news, Read more ...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 17, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") is pleased to announce it has been featured in an article published by Kathy Woudzia regarding the Company's patent-pending discovery of cannabinoid tre...
Ultra-thinly traded nano cap Pascal Biosciences ( OTC:BIMUF +21.7% ) is up on a 10x surge in volume, a scant 24.5K shares, on the heels of its announcement that it has discovered certain cannabinoids that block replication of the SARS-CoV-2 virus. More news on: Pascal Biosciences ...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 14, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has discovered certain cannabinoids that block replication of SARS-CoV-2, the coronavirus that causes COVID-19. In a cell-ba...
News, Short Squeeze, Breakout and More Instantly...
Biommune Technologies Inc Company Name:
BIMUF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise. First,...
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences,...